Drug Type ASO |
Synonyms- |
Target |
Mechanism ACE2 inhibitors(Angiotensin-converting enzyme 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Preclinical | CN | 01 Oct 2024 | |
COVID-19 | Preclinical | CN | 01 Oct 2024 |